AMYRIS, INC.
amyris.comNo Longer Reporting
The company has not filed an annual or quarterly report since its Q1 FY2023 10-Q, filed May 10, 2023. Its latest SEC filing is a 4 from May 7, 2024.
10-Q for Q1 FY2023, filed May 10, 2023
The sections below describe the company as of the FY2022 annual report.
What Did They Do?
Sells beauty and wellness products to consumers and sustainable ingredients to industrial customers serving flavor, fragrance, nutrition, food and personal care markets.
10-K for FY2022, filed Mar 16, 2023Amyris is a biotechnology company delivering sustainable, science-based ingredients and consumer products that are better than incumbent…View ↗
How Did They Make Money?
Customers buy consumer products and ingredients when they ship; licensees pay upfront fees and royalties tied to product sales. Collaboration partners pay for research and development as work progresses or milestones are reached, generally through monthly or quarterly invoices.
10-K for FY2022, filed Mar 16, 2023Revenues from renewable product sales are recognized as a distinct performance obligation on a gross basis as the Company is acting as a…View ↗
Licensing of Intellectual Property: When the Company’s intellectual property licenses are determined to be distinct from the other…View ↗
When the Company’s intellectual property license is the only performance obligation, or it is the predominant performance obligation in…View ↗
Collaborative Research and Development Services: The Company earns revenues from collaboration agreements with customers to perform…View ↗
The Company generally invoices its collaboration partners on a monthly or quarterly basis, or upon the completion of the effort or…View ↗
$269.8M
-
10-K for FY2022, filed Mar 17, 2023
$269.8M ↗
Who Were Their Customers?
Amyris sells consumer products directly to shoppers online and through retail partners, and sells ingredients directly to distributors, formulators, and collaboration partners or through joint ventures.
10-K for FY2022, filed Mar 16, 2023We have various retail partnerships associated with our consumer business including Sephora, Target, Amazon, and Walmart. We also partner…View ↗
We partner with leaders in the broader ingredients sector to bring our unique, sustainably-sourced ingredients to market. Through these…View ↗
We distribute and sell our sustainable consumer products to retailers and directly to consumers through online e-commerce websites. We…View ↗
Did Revenues Turn Into Profits?
No. It lost $528.5M in FY2022.
How Were They Changing?
- Net income
-
Sources
10-Q for Q1 FY2023, filed May 10, 2023
−$201.8MView ↗
- ▲ +83% (Loss)
- vs −$110.2M in Q1 FY2022
-
May 7, 2024
Amyris completed its bankruptcy reorganization
The prior claims were discharged, and new common stock was issued to holders of DIP claims.
Sources
8-K, filed May 7, 2024
On the Effective Date, the Foris Prepetition Secured Lenders did not receive nor retain any property under the Plan on account of the Foris…View ↗
-
Feb 9, 2024
Bankruptcy court confirmed a plan to reorganize Amyris
The plan called for reorganizing its remaining business and assets into a privately held company.
Sources
8-K, filed Feb 9, 2024
On February 7, 2024, the Court entered an order (the “Confirmation Order”) confirming the Plan. The Plan is not yet effective. The Company…View ↗
-
Dec 29, 2023
Amyris sold substantially all Biossance brand assets for $20 million
Sources
8-K, filed Dec 29, 2023
On December 28, 2023, Amyris, Inc. (the “Company”) and THG Beauty USA LLC (“THG”) signed and closed an Asset Purchase Agreement (the “APA”)…View ↗
-
Dec 13, 2023
Court approved sales of MenoLabs and 4U by Tia brand assets
The Biossance, MenoLabs, and 4U by Tia sales were approved, with additional brand sales still in process.
Sources
8-K, filed Dec 13, 2023
On November 30, 2023 and December 1, 2023, the Company conducted auctions for certain of the Debtors’ assets (the “Brand Assets”). At the…View ↗
Grew. Revenue grew 4.2x in 4 years, from $63.6M in FY2018 to $269.8M in FY2022, about 44% a year.
Consumer brands
The older report described selling ingredients through commercialization partners, with a small direct sales and distributor group for Clean Beauty; the latest report also features Amyris's own consumer brands sold online and through retail partners.
10-K for FY2019, filed Mar 13, 2020 10-K for FY2022, filed Mar 16, 2023We believe that industrial biotechnology represents a third industrial revolution, bringing together biology and engineering to generate…View ↗
Loading...
